This stock is no longer traded. It was delisted on July 8, 2026. Prices stop on that date; discussion is still counted.
Generated by AI
Novo Integrated Sciences, Inc. is a diversified healthcare provider specializing in multidisciplinary primary care and wellness services, primarily operating through its subsidiaries in Canada and the United States. The company delivers an integrated suite of healthcare solutions, encompassing physiotherapy, chiropractic and manual therapies, occupational therapy, eldercare, massage therapy, acupuncture, neurological rehabilitation, and specialized programs for brain injury, concussion management, and women’s health. These services target a broad spectrum of patients, including pediatric, adult, and geriatric populations, across outpatient clinics as well as long-term care and community settings. In addition to clinical services, Novo Integrated Sciences develops, manufactures, and distributes wellness products such as micro-dosing iodine solutions and dietary supplement pouches. The company incorporates advanced medical technology—including telemedicine platforms, remote patient monitoring, and personalized health diagnostics—to enhance patient outcomes and broaden its market reach. By integrating rehabilitative science with medical innovation, Novo Integrated Sciences positions itself as a unique player addressing evolving needs in the healthcare sector, with its revenue primarily generated from Canadian clinical operations and product sales.
Website11120 NE 2nd Street
Bellevue, WA, 98004
United States
Summary of Nov 8's posts. Generated by AI.
Summary of Aug 16's posts. Generated by AI.
Summary of Sep 22's posts. Generated by AI.
Investors talking about NVOS also mention these. Each card shows that asset’s own numbers for the past 24 hours.